Weaning from Venovenous Extracorporeal Membrane Oxygenation without Anticoagulation: Is it Possible?
Based on this single experience, management and weaning without any anticoagulant agent might be possible.
Advances in Platelet Function Testing Assessing Bleeding Complications in Patients with Coronary Artery Disease
The present manuscript will review the prognostic value of platelet function testing to identify patients with CAD at risk of bleeding complications and the potential applications of these tests in the modern era of antiplatelet pharmacotherapy.
Heparin Brand is Associated with Postsurgical Outcomes in Children Undergoing Cardiac Surgery
Brand of unfractionated heparin used during cardiopulmonary bypass for pediatric cardiac surgery was associated with bleeding complications and clinical outcomes.
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Severe Respiratory Failure in Japan
To evaluate procedures and outcomes of extracorporeal membrane oxygenation (ECMO) therapy applied to 2009 influenza A(H1N1) severe respiratory failure patients in Japan.
First Experience with the New Portable Extracorporeal Membrane Oxygenation System Cardiohelp for Severe Respiratory Failure in Adults
In this report, we present our early experience with the Cardiohelp, a new portable miniaturized ECMO system, in 22 consecutive patients with ARDS.
Institution of Extracorporeal Membrane Oxygenation Late after Lung Transplantation – A Futile Exercise?
Late institution of ECMO in lung transplant recipients for causes other than primary graft failure is associated with such poor survival that its use should be considered only in very select cases.
Selective Cerebral Perfusion with 4-Branch Graft Total Aortic Arch Replacement: Outcomes in 12 Patients.
Our purpose is to describe our experience using a 4-branched graft and selective antegrade brain perfusion (SABP) for total aortic arch replacement (TAR).
Peripheral Extracorporeal Membrane Oxygenation System as Salvage Treatment of Patients with Refractory Cardiogenic Shock: Preliminary Outcome Evaluation
The novel Permanent Life Support (PLS; Maquet, Jostra Medizintechnik AG, Hirrlingen, Germany) as peripheral veno-arterial extracorporeal membrane oxygenation (ECMO) support system has been investigated as treatment for patients with refractory cardiogenic shock (CS).
Outcome of Patients with Profound Cardiogenic Shock after Cardiopulmonary Resuscitation and Prompt Extracorporeal Membrane Oxygenation Support. A Single-Center Observational Study
Profound CS was associated with high mortality. Both successful weaning from ECMO and an APACHE II score might serve as outcome predictors for risk stratification.
Effect of Mean Arterial Pressure, Haemoglobin and Blood Transfusion During Cardiopulmonary Bypass on Post-Operative Acute Kidney Injury
Acute kidney injury (AKI) after cardiac surgery is a common and serious condition carrying significant costs
Breast Implants and Minimally Invasive Cardiac Surgery: A Case Series
Our series of 5 patients demonstrates that minimally invasive heart surgery performed through an inframammary incision can be safely performed in those with breast implants.
20-year Experience of Prolonged Extracorporeal Membrane Oxygenation in Critically Ill Children with Cardiac or Pulmonary Failure
This study aimed to study morbidity and mortality associated with prolonged ECMO therapy (≥28 days) in children with refractory cardiac or pulmonary failure.